You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
開能健康(300272.SZ):擬斥4550萬元參與對原能生物增資
格隆匯 12-20 18:04

格隆匯 12 月 20日丨開能健康(300272.SZ)公佈,公司擬與其他12家投資人共同簽署《增資協議》並向原能生物進行增資,其中,公司擬投資4,550萬元,認購原能生物新增註冊資本1,300萬元(持有其6.57%的股權)。

據悉,原能生物是公司參股公司原能細胞科技集團有限公司(以下簡稱"原能集團"或"原股東")於2017年5月投資設立的子公司。原能生物是一家致力於先進生物醫學裝備的技術研發、產品設計與製造。以自動化、智能化的深低温生物樣本存儲設備為核心重點,以解決前沿生物醫療產業上下游的生物樣本凍存痛點為目標,集研發、設計、製造、銷售和服務為一體的高科技細胞生物醫學裝備企業。

公告稱,公司此次通過向原能生物增資方式持有其6.57%的股權,系基於近年來生命科學和醫藥產業飛速發展,公司積極看好原能生物從事的自動化及定製化生物存儲設備市場的長遠發展而作出的戰略性財務投資。雖然原能生物目前尚未盈利,但隨着其主營產品市場的不斷擴大,其銷售收入及盈利能力預期將大幅提升,發展前景值得期待。此次增資將有利於公司進一步完善在健康產業生態圈的投資佈局,也有利於公司全體股東的長遠利益。

Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account